179 related articles for article (PubMed ID: 26389777)
21. Adhesive properties: a critical issue in transdermal patch development.
Cilurzo F; Gennari CG; Minghetti P
Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
[TBL] [Abstract][Full Text] [Related]
22. What is the future of heated transdermal delivery systems?
Otto DP; de Villiers MM
Ther Deliv; 2014; 5(9):961-4. PubMed ID: 25375338
[No Abstract] [Full Text] [Related]
23. Recent advances on self modified patch for (trans) dermal drug delivery.
Pandey S; Patil A
Recent Pat Drug Deliv Formul; 2015; 9(1):88-94. PubMed ID: 24981287
[TBL] [Abstract][Full Text] [Related]
24. Recent developments in silicones for topical and transdermal drug delivery.
Aliyar H; Schalau G
Ther Deliv; 2015 Jul; 6(7):827-39. PubMed ID: 26228774
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: a technical note.
Satturwar PM; Fulzele SV; Dorle AK
AAPS PharmSciTech; 2005 Dec; 6(4):E649-54. PubMed ID: 16408867
[TBL] [Abstract][Full Text] [Related]
26. The transdermal delivery of fentanyl.
Lane ME
Eur J Pharm Biopharm; 2013 Aug; 84(3):449-55. PubMed ID: 23419814
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in polymeric transdermal drug delivery systems.
Sabbagh F; Kim BS
J Control Release; 2022 Jan; 341():132-146. PubMed ID: 34813879
[TBL] [Abstract][Full Text] [Related]
28. [Transdermal therapeutic systems for drug administration].
Hupfeld S; Gravem H
Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
[TBL] [Abstract][Full Text] [Related]
29. Transdermal drug delivery of labetolol hydrochloride: system development, in vitro; ex vivo and in vivo characterization.
Aqil M; Zafar S; Ali A; Ahmad S
Curr Drug Deliv; 2005 Apr; 2(2):125-31. PubMed ID: 16305413
[TBL] [Abstract][Full Text] [Related]
30. Breaking boundaries: the advancements in transdermal delivery of antibiotics.
Zaid Alkilani A; Hamed R; Musleh B; Sharaire Z
Drug Deliv; 2024 Dec; 31(1):2304251. PubMed ID: 38241087
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
32. Establishment and Validation of a Transdermal Drug Delivery System for the Anti-Depressant Drug Citalopram Hydrobromide.
Sun YY; Ni YJ; Wang RJ; Qin ZC; Liu Z; Xiao LH; Liu YQ
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398519
[TBL] [Abstract][Full Text] [Related]
33. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
[TBL] [Abstract][Full Text] [Related]
34. Solid-State Stability Issues of Drugs in Transdermal Patch Formulations.
Sharma PK; Panda A; Pradhan A; Zhang J; Thakkar R; Whang CH; Repka MA; Murthy SN
AAPS PharmSciTech; 2018 Jan; 19(1):27-35. PubMed ID: 28895101
[TBL] [Abstract][Full Text] [Related]
35. Delivering drugs by the transdermal route: review and comment.
Tanner T; Marks R
Skin Res Technol; 2008 Aug; 14(3):249-60. PubMed ID: 19159369
[TBL] [Abstract][Full Text] [Related]
36. Application of confocal laser scanning microscopy in characterization of chemical enhancers in drug-in-adhesive transdermal patches.
Qvist MH; Hoeck U; Kreilgaard B; Madsen F; Hovgaard L; Frokjaer S
AAPS PharmSci; 2002; 4(1):E3. PubMed ID: 12049487
[TBL] [Abstract][Full Text] [Related]
37. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
[TBL] [Abstract][Full Text] [Related]
38. Navigating sticky areas in transdermal product development.
Strasinger C; Raney SG; Tran DC; Ghosh P; Newman B; Bashaw ED; Ghosh T; Shukla CG
J Control Release; 2016 Jul; 233():1-9. PubMed ID: 27117457
[TBL] [Abstract][Full Text] [Related]
39. Transdermal drug delivery: useful paradigms.
Potts RO; Cleary GW
J Drug Target; 1995; 3(4):247-51. PubMed ID: 8820998
[TBL] [Abstract][Full Text] [Related]
40. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Soler LI; Boix A; Lauroba J; Colom H; Domenech J
Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
